Euro-Med Laboratories Phil., Inc. (PSE:EURO)

Philippines · Delayed Price · Currency is PHP

1.280

+0.090 (7.56%)

At close: Sep 17, 2026

Market Cap	5.26B +43.8%
Revenue (ttm)	6.92B +5.9%
Net Income	510.62M +32.2%
EPS	0.12 +33.3%
Shares Out	4.11B
PE Ratio	10.67
Forward PE	n/a
Dividend	0.07 (5.47%)
Ex-Dividend Date	Nov 13, 2025

Volume	4,000
Open	1.190
Previous Close	1.190
Day's Range	1.190 - 1.280
52-Week Range	0.860 - 1.460
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About PSE:EURO

Euro-Med Laboratories Phil., Inc. manufactures and sells various pharmaceutical products in the Philippines and internationally. The company manufactures and distributes large and small volume parenterals that are used as solvents for other drugs; sterile water for injection; and other solutions for ophthalmic, inhalation, irrigation, and dialysis. It also offers specialty fluids comprising dialysis solutions for the treatment of acute or chronic renal failure; hemodialysis solution, a concentrated solution of electrolytes in water for injectio... [Read more]

Industry Pharmaceuticals

Sector Healthcare

Founded 1988

Employees 1,811

Stock Exchange Philippine Stock Exchange

Ticker Symbol EURO

Full Company Profile

Financial Performance

In 2025, PSE:EURO's revenue was 6.87 billion, an increase of 18.50% compared to the previous year's 5.80 billion. Earnings were 470.30 million, an increase of 39.27%.

Financial Statements